Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Relieve Symptom

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

BMC Palliative Care ◽

10.1186/s12904-019-0494-6 ◽

2019 ◽

Vol 18 (1) ◽

Cited By ~ 2

Author(s):

Phillip Good ◽

Alison Haywood ◽

Gauri Gogna ◽

Jennifer Martin ◽

Patsy Yates ◽

...

Keyword(s):

Clinical Trial ◽

Palliative Care ◽

Advanced Cancer ◽

Symptom Burden ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Relieve Symptom

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04508.x ◽

2010 ◽

Vol 33 (2) ◽

pp. 213-224 ◽

Cited By ~ 22

Author(s):

Y. Kinoshita ◽

K. Ashida ◽

M. Hongo ◽

Keyword(s):

Clinical Trial ◽

Reflux Disease ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo

Faculty Opinions recommendation of Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717953846.793459520 ◽

2012 ◽

Author(s):

Matthew DiMagno ◽

Erik Wamsteker

Keyword(s):

Clinical Trial ◽

Controlled Study ◽

Efficacy And Safety ◽

Pancreatic Exocrine Insufficiency ◽

Exocrine Insufficiency ◽

Double Blind ◽

Double Blind Placebo ◽

Pancreatic Exocrine ◽

Enteric Coated

Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-203164 ◽

2013 ◽

Vol 73 (9) ◽

pp. 1665-1672 ◽

Cited By ~ 47

Author(s):

Andra Rodica Balanescu ◽

Eugen Feist ◽

Gernot Wolfram ◽

Isabelle Davignon ◽

Michael D Smith ◽

...

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793483435 ◽

2013 ◽

Author(s):

Josimari Melo DeSantana

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482796 ◽

2013 ◽

Author(s):

Carsten Bantel

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - a double-blind, placebo-controlled study

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2012.05202.x ◽

2012 ◽

Vol 36 (5) ◽

pp. 426-436 ◽

Cited By ~ 39

Author(s):

V. Thorat ◽

N. Reddy ◽

S. Bhatia ◽

A. Bapaye ◽

J. S. Rajkumar ◽

...

Keyword(s):

Clinical Trial ◽

Controlled Study ◽

Efficacy And Safety ◽

Pancreatic Exocrine Insufficiency ◽

Exocrine Insufficiency ◽

Double Blind ◽

Double Blind Placebo ◽

Pancreatic Exocrine ◽

Enteric Coated

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2011.04818.x ◽

2011 ◽

Vol 34 (8) ◽

pp. 868-877 ◽

Cited By ~ 27

Author(s):

J. F. Tack ◽

P. B. Miner ◽

L. Fischer ◽

M. S. Harris

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Controlled Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Irritable Bowel

447-P: The Efficacy and Safety Trial of ENERGI-F703 in Diabetic Wound Healing: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial

Diabetes ◽

10.2337/db21-447-p ◽

2021 ◽

Vol 70 (Supplement 1) ◽

pp. 447-P

Author(s):

GUANG-HUAR YOUNG ◽

JIUN-TSAI LIN ◽

YI-FANG CHENG ◽

HAN-MIN CHEN ◽

CHUN-FANG HUANG

Keyword(s):

Clinical Trial ◽

Wound Healing ◽

Diabetic Wound ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Clinical Trial ◽

Diabetic Wound Healing